SUBSCRIBE
SUBSCRIBE
News   Business

Entelos, Inc. Enters Research Deal with UCB Pharma in Rheumatoid Arthritis

January 21, 2008 | 
1 min read
LONDON (Thomson Financial) - Entelos Inc said it has signed a research deal with UCB Pharma S A to conduct in silico research in the field of rheumatoid arthritis using the Entelos Rheumatoid Arthritis PhysioLab platform.
Alliances Europe
MORE ON THIS TOPIC
Facade of AstraZeneca's office in Shanghai, China
Artificial intelligence
AstraZeneca Makes Another AI Deal With $555M Algen Alliance
October 6, 2025
 · 
2 min read
 · 
Tristan Manalac
Two human hands with a gesture of a handshake agreement and dollar banknotes with dollar signs on a colored background. Concept of business contract or agreement. Collage art
Mergers & acquisitions
Chiesi, Arbor Weave $2.1B Rare Disease Pact
October 6, 2025
 · 
1 min read
 · 
Tristan Manalac
Group of blue paper boats following on red on yellow background, mass manipulation
Mergers & acquisitions
How Akero’s MASH Success Drove Roche’s $3.5B Takeout of 89bio
October 2, 2025
 · 
3 min read
 · 
Annalee Armstrong
Hand shake icon on wooden cube block which connection with human icon for business deal and agreement concept.
Mergers & acquisitions
Halozyme’s $900M Elektrofi Buyout Brings Two Big Pharma Partners Together
October 2, 2025
 · 
2 min read
 · 
Tristan Manalac